Search for a functional glucocorticoid receptor in the mammalian lens

Experimental Eye Research

Volumn 88, Issue 2, 2009, Pages 248-256

  Gupta, Vanita ^a   Wagner, B J ^b,c,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^d University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

AKT; GILZ; glucocorticoid receptor; lens epithelium; MAPK; MKP 1; posterior subcapsular cataract

Indexed keywords

ALPHA CRYSTALLIN; CORTISONE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; LEUCINE ZIPPER PROTEIN; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR; PREDNISOLONE; PROTEIN KINASE B;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BINDING AFFINITY; CATARACTOGENESIS; CELL COMMUNICATION; CELL DEGENERATION; CELL FUNCTION; CELL MATURATION; CELL MEMBRANE PERMEABILITY; CELL MOTION; CELL PROLIFERATION; CHICK EMBRYO; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LENS; LENS EPITHELIUM; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RABBIT; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STEM CELL; SUBCAPSULAR CATARACT; TREATMENT DURATION;

ANIMALS; CATARACT; CELL DEATH; CELL PROLIFERATION; EPITHELIAL CELLS; GLUCOCORTICOIDS; HUMANS; LENS, CRYSTALLINE; MAMMALS; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 61849137196     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.04.003     Document Type: Review

References (118)

1. Amsterdam A., and Sasson R. The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis. Mol. Cell. Endocrinol. 189 (2002) 1-9
2. Andrade M.V., Hiragun T., and Beaven M.A. Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J. Immunol. 172 (2004) 7254-7262
3. Ansell B.M. Overview of the side effects of corticosteroid therapy. Clin. Exp. Rheumatol. 9 (1991) 19-20
4. Aranda A., and Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81 (2001) 1269-1304
5. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., and Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268-275
6. Ayroldi E., Zollo O., Macchiarulo A., Di Marco B., Marchetti C., and Riccardi C. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol. Cell Biol. 22 (2002) 7929-7941
7. Balendran A., Casamayor A., Deak M., Paterson A., Gaffney P., Currie R., Downes C.P., and Alessi D.R. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol. 9 (1999) 393-404
8. Bamberger C.M., Bamberger A.M., de Castro M., and Chrousos G.P. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95 (1995) 2435-2441
9. Baulieu E.E. The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications. Endocrinol. Metab. Clin. North Am. 20 (1991) 873-891
10. Baxter J.D., and Rousseau G.G. Glucocorticoid hormone action: an overview. Monogr. Endocrinol. 12 (1979) 1-24
11. Bazuine M., Carlotti F., Tafrechi R.S., Hoeben R.C., and Maassen J.A. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 18 (2004) 1697-1707
12. Becker B. Cataracts and topical corticosteroids. Am. J. Ophthalmol. 58 (1964) 872-873
13. Bernardi R.J., Trump D.L., Yu W.D., McGuire T.F., Hershberger P.A., and Johnson C.S. Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin. Cancer Res. 7 (2001) 4164-4173
14. Bertorelli G., Bocchino V., and Olivieri D. Heat shock protein interactions with the glucocorticoid receptor. Pulm. Pharmacol. Ther. 11 (1998) 7-12
15. Black R.L., Oglesby R.B., von Sallman L., and Bunim J.J. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 174 (1960) 166-171
16. Bomberger C.E., and Haar J.L. Dexamethasone and hydrocortisone enhance the in vitro migration of prethymic stem cells to thymus supernatant. Thymus 20 (1992) 89-99
17. Bomser J.A. Selective induction of mitogen-activated protein kinases in human lens epithelial cells by ultraviolet radiation. J. Biochem. Mol. Toxicol. 16 (2002) 33-40
18. Bouzas E.A., Mastorakos G., Friedman T.C., Scott M.H., Chrousos G.P., and Kaiser-Kupfer M.I. Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation. Invest. Ophthalmol. Vis. Sci. 34 (1993) 3497-3500
19. Bucala R., Fihamn J., and Cerami A. Formation of covalent adducts between cortisol and 16alpha hydroxyl-esterone and protein: possible role in the pathogenesis of cortisol toxicity and the systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 3320-3324
20. Bucala R., Gallati M., Manabe S., Cotlier E., and Cerami A. Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts. Exp. Eye Res. 40 (1985) 853-863
21. Burnstein K.L., Bellingham D.L., Jewell C.M., Powell-Oliver F.E., and Cidlowski J.A. Autoregulation of glucocorticoid receptor gene expression. Steroids 56 (1991) 52-58
22. Chan A. Ras-MAPK pathways. Sci STKE (2005) 2005:tr5
23. Chandrasekher G., and Sailaja D. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3577-3588
24. Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L., Franklin R.A., and McCubrey J.A. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17 (2003) 590-603
25. Chapman K.E., Kotelevtsev Y.V., Jamieson P.M., Williams L.J., Mullins J.J., and Seckl J.R. Tissue-specific modulation of glucocorticoid action by the 11 beta-hydroxysteroid dehydrogenases. Biochem. Soc. Trans. 25 (1997) 583-587
26. Chaudhary A., King W.G., Mattaliano M.D., Frost J.A., Diaz B., Morrison D.K., Cobb M.H., Marshall M.S., and Brugge J.S. Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr. Biol. 10 (2000) 551-554
27. Choi J., Park S.Y., and Joo C.K. Hepatocyte growth factor induces proliferation of lens epithelial cells through activation of ERK1/2 and JNK/SAPK. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2696-2704
28. Clark A.R., and Lasa M. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Apoptosis 9 (2004) 667-676
29. Clark J.V. Complications of steroid therapy. Manit. Med. Rev. 48 (1968) 454-461
30. Cole T.J., Myles K., Purton J.F., Brereton P.S., Solomon N.M., Godfrey D.I., and Funder J.W. GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant. Mol. Cell. Endocrinol. 173 (2001) 193-202
31. Dickerson Jr. J.E., Dotzel E., and Clark A.F. Steroid-induced cataract: new perspective from in vitro and lens culture studies. Exp. Eye Res. (1997) 65507-65516
32. Distelhorst C.W. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 9 (2002) 6-19
33. Engelbrecht Y., de Wet H., Horsch K., Langeveldt C.R., Hough F.S., and Hulley P.A. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144 (2003) 412-422
34. Eshaghian J., and Streeten B.W. Human posterior subcapsular cataract. An ultrastructural study of the posteriorly migrating cells. Arch. Ophthalmol. 98 1 (1980) 134-143
35. Eshagian J. Human posterior subcapsular cataracts. Trans. Ophthalmol. Soc. U.K. 102 (1982) 364-368
36. Frangie J.P., and Leibowitz H.M. Steroids. Int. Ophthalmol. Clin. 33 (1993) 9-29
37. Fuenfer M.M., Olson G.E., and Polk Jr. H.C. Effect of various corticosteroids upon the phagocytic bactericidal activity of neutrophils. Surgery 78 (1975) 27-33
38. Gao H.B., Tong M.H., Hu Y.Q., Guo Q.S., Ge R., and Hardy M.P. Glucocorticoid induces apoptosis in rat leydig cells. Endocrinology 143 (2002) 130-138
39. Giguere V., Hollenberg S.M., Rosenfeld M.G., and Evans R.M. Functional domains of the human glucocorticoid receptor. Cell 46 (1986) 645-652
40. Giles C.L., Mason G.L., Duff I.F., and McLean J.A. The association of cataract formation and systemic corticosteroid therapy. JAMA 182 (1962) 719-722
41. Gong X., Wang X., Han J., Niesman I., Huang Q., and Horwitz J. Development of cataractous macrophthalmia in mice expressing an active MEK1 in the lens. Invest. Ophthalmol. Vis. Sci. 42 (2001) 539-548
42. Gonzalez M.V., Gonzalez-Sancho J.M., Caelles C., Munoz A., and Jimenez B. Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells. FEBS Lett. 459 (1999) 272-276
43. Greiner J.V., and Chylack Jr. L.T. Posterior subcapsular cataracts: histopathologic study of steroid-associated cataracts. Arch. Ophthalmol. 97 (1979) 135-144
44. Gupta V., Awasthi N., and Wagner B.J. Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1724-1734
45. Gupta V., Galante A., Soteropoulos P., Guo S., and Wagner B.J. Global gene profiling reveals novel glucocorticoid induced changes in gene expression of human lens epithelial cells. Mol. Vis. 11 (2005) 1018-1040
46. Gupta V., and Wagner B.J. Expression of the functional glucocorticoid receptor in mouse and human lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2041-2046
47. Harve D.C. Cataracts in children on long-term corticosteroid therapy. Arch. Ophthalmol. 73 (1965) 818-821
48. Hideshima T., Nakamura N., Chauhan D., and Anderson K.C. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 20 (2001) 5991-6000
49. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., Thompson E.B., Rosenfeld M.G., and Evans R.M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 (1985) 635-641
50. Ismaili N., and Garabedian M.J. Modulation of glucocorticoid receptor function via phosphorylation. Ann. N.Y. Acad. Sci. 1024 (2004) 86-101
51. Jacob T.J., Karim A.K., and Thompson G.M. The effects of steroids on the human lens epithelium. Eye 1 (1987) 722-727
52. James E.R., Fresco V.M., and Robertson L.L. Glucocorticoid-induced changes in the global gene expression of lens epithelial cells. J. Ocul. Pharmacol. Ther. 21 (2005) 11-27
53. James E.R., Robertson L., Ehlert E., Fitzgerald P., Droin N., and Green D.R. Presence of a transcriptionally active glucocorticoid receptor alpha in lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 44 12 (2003 Dec) 5269-5276
54. James E.R. The etiology of steroid cataract. J. Ocul. Pharmacol. Ther. 23 (2007) 403-420
55. Jobling A.I., and Augusteyn R.C. Is there a glucocorticoid receptor in the bovine lens?. Exp. Eye. Res. 72 (2001) 687-694
56. Jobling A.I., Stevens A., and Augusteyn R.C. Binding of dexamethasone by α-crystalline. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1829-1832
57. Karim A.K., Jacob T.J., and Thompson G.M. The human anterior lens capsule: cell density, morphology and mitotic index in normal and cataractous lenses. Exp. Eye. Res. 45 (1987) 865-874
58. Kassel O., Sancono A., Kratzschmar J., Kreft B., and Stassen M. Cato AC Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20 (2001) 7108-7116
59. Kawamura A., Tamaki N., and Kokunai T. Effect of dexamethasone on cell proliferation of neuroepithelial tumor cell lines. Neurol. Med. Chir. 38 (1998) 638-640
60. Kaye L.D., Kalenak J.W., Price R.L., and Cunningham R. Ocular implications of long term prednisone therapy in children. J. Pediatr. Ophthalmol. Strabismus. 30 (1993) 142-144
61. Kimberly R.P. Mechanisms of action, dosage schedules, and side effects of steroid therapy. Curr. Opin. Rheumatol. 3 (1991) 373-379
62. Knisely T.L., Hosoi J., Nazareno R., and Granstein R.D. The presence of biologically significant concentrations of glucocorticoids but little or no cortisol binding globulin within aqueous humor: relevance to immune privilege in the anterior chamber of the eye. Invest. Ophthalmol. Vis. Sci. 35 (1994) 3711-3723
63. Lamberts S.W. Glucocorticoid receptors and Cushing's disease. Mol. Cell. Endocrinol. 197 (2002) 69-72
64. Laprise P., Langlois M.J., Boucher M.J., Jobin C., and Rivard N. Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. J. Cell Physiol. 199 (2004) 32-39
65. Lee E.J., Park H.G., and Kang H.S. Sodium salicylate induces apoptosis in HCT116 colorectal cancer cells through activation of p38MAPK. Int. J. Oncol. 23 (2003) 503-508
66. Lee M.J., Wang Z., Yee H., Ma Y., Swenson N., Yang L., Kadner S.S., Baergen R.N., Logan S.K., Garabedian M.J., and Guller S. Expression and regulation of glucocorticoid receptor in human placental villous fibroblasts. Endocrinology 146 (2005) 4619-4626
67. Lombes M., Binart N., Oblin M.E., Joulin V., and Baulieu E.E. Characterization of the interaction of the human mineralocorticosteroid receptor with hormone response elements. Biochem. J. 292 (1993) 577-583
68. Long A.C., Colitz C.M., and Bomser J.A. Apoptotic and necrotic mechanisms of stress-induced human lens epithelial cell death. Exp. Biol. Med. (Maywood). 229 (2004) 1072-1080
69. Lyu J., Kim J.A., Chung S.K., and Kim K.S. Joo CK Alteration of cadherin in dexamethasone-induced cataract organ-cultured rat lens. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2034-2040
70. Manabe S., Bucala R., and Cermai A. Nonenzymatic addition of glucocorticoids to lens proteins in steroid induced cataract J. Clin. Invest. 74 (1984) 1803-1810
71. Mansfield K.J., Cerra A., and Chamberlain C.G. Effects of dexamethasone on posterior capsule opacification-like changes in a rat lens explant model. Mol. Vis. 10 (2004) 728-737
72. Matsumoto T., Takeyama K., Sato T., and Kato S. Androgen receptor functions from reverse genetic models. J. Steroid. Biochem. Mol. Biol. 85 (2003) 95-99
73. Meier F., Schittek B., Busch S., Garbe C., Smalley K., Satyamoorthy K., Li G., and Herlyn M. The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front. Biosci. 10 (2005) 2986-3001
74. Mittelstadt P.R., and Ashwell J.D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276 (2001) 29603-29610
75. Murakami I., Kosano H., Ogihara-Umeda I., Nishigori H., Uga S., and Ishikawa S. Comparison of lens biochemistry and structure between BSO-treated and glucocorticoid-treated developing chick embryos. Exp. Eye Res. 63 (1996) 673-681
76. Nishigori H., Lee J.W., Yamauchi Y., and Iwatsuru M. The alteration of lipid peroxide in glucocorticoid-induced cataract of developing chick embryos and the effect of ascorbic acid. Curr. Eye Res. 5 (1986) 37-40
77. Noguchi T., Metz R., Chen L., Mattei M.G., Carrasco D., and Bravo R. Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol. Cell Biol. 13 (1993) 5195-5205
78. Oakley R.H., Webster J.C., Sar M., Parker Jr. C.R., and Cidlowski J.A. Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology 138 (1997) 5028-5038
79. Obenberger J., Starka L., and Hampl R. Quantitative determination of endogenous corticosteroids in the rabbit plasma and aqueous humor. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 183 (1971) 203-209
80. Ogelsby R.B., Black R.L., Von Sallmann L., and Bunim J.J. Cataracts in rheumatoid arthritis patients treated with corticosteroids. Description and differential diagnosis. Arch. Ophthalmol. 66 (1961) 519-523
81. O'Malley B.W. Mechanisms of action of steroid hormones. N. Engl. J. Med. 284 (1971) 370-377
82. Orth D.N., and Kovacs W.J. Molecular mechanisms of adrenal steroid action. In: Larsen P.R., Wilson J.M., Kronenberg H.M., Foster D.W., and Williams R.H. (Eds). Williams Text Book of Endocrinology. ninth ed. (1998), W.B Saunders Company, Philadelphia 541-544
83. Orti E., Hu L.M., and Munck A. Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J. Biol. Chem. 268 (1993) 7779-7784
84. Orti E., Mendel D.B., Smith L.I., and Munck A. Agonist-dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells. J. Biol. Chem. 264 (1989) 9728-9731
85. Pescosolido N., Miccheli A., Manetti C., Iannetti G.D., Feher J., and Cavallotti C. Metabolic changes in rabbit lens induced by treatment with dexamethasone. Ophthalmic. Res. 33 (2001) 68-74
86. Pujols L., Mullol J., Roca-Ferrer J., Torrego A., Xaubet A., Cidlowski J.A., and Picado C. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am. J. Physiol. Cell Physiol. 283 (2002) C1324-C1331
87. Reichardt H.M., Tuckermann J.P., Gottlicher M., Vujic M., Weih F., Angel P., Herrlich P., and Schutz G. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20 (2001) 7168-7173
88. Rowan B.G., and Ip M.M. Charge Heterogeneity in wildtype and variant glucocorticoid receptors. Mol. Cell. Endocrinol. 107 (1995) 41-54
89. Rupprecht R., Reul J.M., van Steensel B., Spengler D., Soder M., Berning B., Holsboer F., and Damm K. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. 247 (1993) 145-154
90. Russcher H., van Rossum E.F., de Jong F.H., Brinkmann A.O., Lamberts S.W., and Koper J.W. Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism. Mol. Endocrinol. 19 (2005) 1687-1696
91. Saklatvala J. Glucocorticoids: do we know how they work?. Arthritis Res. 4 (2002) 146-150
92. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J. 9 (1995) 726-735
93. Seth A., and Aggarwal A. Monitoring adverse reaction to steroid therapy in children. Indian Pediatr. 41 (2004) 349-357
94. Shepard A.R., Jacobson N., Fingert J.H., Stone E.M., Sheffield V.C., and Clark A.F. Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 42 (2001) 3173-3181
95. Slater E.P., Anderson T., Cattini P., Isaacs R., Birnbaum M.J., Gardner D.G., Eberhardt N.L., and Baxter J.D. Mechanisms of glucocorticoid hormone action. Adv. Exp. Med. Biol. 196 (1986) 67-80
96. Southren A.L., Gorden G.G., Yeh H.S., Dunn M.W., and Weinstein B.I. Receptors for glucocorticoids in the lens epithelium of the calf. Science 200 (1978) 1177-1178
97. Stokes J., Noble J., Lawrence B., Phillips C., Seckl J., O'Brien C., and Andrew R. Distribution of glucocorticoid and mineralocorticoid receptors and 11-bhydroxy-steriod dehydrogenases in human and rat ocular tissues. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1629-1638
98. Suzuki T., Sasano H., Kaneko C., Ogawa S., Darnel A.D., and Krozowski S. Immunohistochemical distribution of 11b-hydroxysteroid dehydrogenase in human eye. Mol. Cell. Endocrinol. 173 (2001) 121-125
99. Symonds J.G., Lovicu F.J., and Chamberlain C.G. Differing effects of dexamethasone and diclofenac on posterior capsule opacification-like changes in a rat lens explant model. Exp. Eye Res. 83 (2006) 771-782
100. Theodosiou A., and Ashworth A. MAP kinase phosphatases. Genome Biol. 3 (2002) 3009
101. Thomas T.P. The complications of systemic corticosteroid therapy in the elderly. A retrospective study. Gerontology 30 (1984) 60-65
102. Thompson E.B., and Lippman M.E. Mechanism of action of glucocorticoids. Metabolism 23 2 (1974) 159-202
103. Urban Jr. R.C., and Cotlier E. Corticosteroid-induced cataracts. Surv. Ophthalmol. 31 (1986) 102-110
104. van Venrooij W.J., Groeneveld A.A., Bloemendal H., and Benedetti E.L. Cultured calf lens epithelium. II The effect of dexamethasone. Exp. Eye Res. 18 (1974) 527-536
105. Wang E., Zhao M., Forrester J.V., and McCaig C.D. Electric fields and MAP kinase signaling can regulate early wound healing in lens epithelium. Invest. Ophthalmol. Vis. Sci. 44 (2003) 244-249
106. Wang Z., Malone M.H., Thomenius M.J., Zhong F., Xu F., and Distelhorst C.W. Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals. J. Biol. Chem. 278 (2003) 27053-27058
107. Watanabe H., Kosano H., and Nishigori H. Steroid induced short-term diabetes in chick embryos: reversible effects of insulin on metabolic changes and cataract formation. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1846-1852
108. Weintraub J.M., Willett W.C., Rosner B., Colditz G.A., Seddon J.M., and Hankinson S.E. A prospective study of the relationship between body mass index and cataract extraction among US women and men. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 1588-1595
109. Wenk E.J., Hernandez M.R., Weinstein B.I., Gordon G.G., Dunn M.W., and Southren A.L. Glucocorticoid receptor binding in bovine lens. Invest. Ophthalmol. Vis. Sci. 22 (1982) 599-605
110. Williamson J., Paterson R.W., McGavin D.D.M., Jasani M.K., Boyle J.A., and Doig W.M. Posterior subcapsular cataracts and glaucoma associated with long-term oral corticosteroid therapy in patients with rheumatoid arthritis and related conditions. Br. J. Ophthamol. 53 (1969) 361-372
111. Wu J.J., and Bennett A.M. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling. J. Biol. Chem. 280 (2005) 16461-16466
112. Wu W., Pew T., Zou M., Pang D., and Conzen S.D. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. J. Biol. Chem. 280 (2005) 4117-4124
113. Yudt M.R., and Cidlowski J.A. Molecular identification and characterization of a and b forms of the glucocorticoid receptor. Mol. Endocrinol. 15 (2001) 1093-1103
114. Zatechka Jr. D.S., Kador P.F., Garcia-Castineiras S., and Lou M.F. Diabetes can alter the signal transduction pathways in the lens of rats. Diabetes 52 (2003) 1014-1022
115. Zatechka Jr. S.D., and Lou M.F. Studies of the mitogen-activated protein kinases and phosphatidylinositol-3 kinase in the lens. 1. The mitogenic and stress responses. Exp. Eye Res. 74 (2002) 703-717
116. Zhang J.P., Wong C.K., and Lam C.W. Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils. Clin. Exp. Immunol. 122 (2000) 20-27
117. Zhou J.M., Zhu X.F., Pan Q.C., Liao D.F., Li Z.M., and Liu Z.C. Manumycin inhibits cell proliferation and the Ras signal transduction pathway in human hepatocellular carcinoma cells. Int. J. Mol. Med. 11 (2003) 767-771
118. Zhu X.L., Sexton P.S., and Cenedella R.J. Characterization of membrane steroid binding protein mRNA and protein in lens epithelial cells. Exp. Eye Res. 73 (2001) 213-219